Please assess the completion status of the following clinical trial:

Trial Title: Clinical Comparison of Silicone Hydrogel Monthly Lenses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Sign Informed Consent;~* Best corrected visual acuity (BCVA) of at least 0.1 logarithm of the minimum angle of resolution (logMAR) in each eye at Visit 1;~* Manifest cylinder less than or equal to 0.75 diopter (D) in each eye at Visit 1;~* Successful current wearer (during the past 2 months for a minimum of 5 days per week and 8 hours per day) of monthly replacement silicone hydrogel lenses within the power range of lens powers available for the screening and study lenses;~* Screening lenses worn 10 hours exhibiting high lipid uptake.~Exclusion Criteria:~* Habitual lens used in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) during the past 2 months;~* Habitually wearing AIR OPTIX AQUA, AIR OPTIX plus HydraGlyde, ACUVUE OASYS®, or ACUVUE VITA as contact lenses during the past 2 months;~* Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear (within 7 days of enrollment, or current)~* History of herpetic keratitis, corneal surgery, or irregular cornea;~* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;~* Abnormal ocular conditions or findings, as specified in the protocol;~* Known pregnancy and lactation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lotrafilcon B, then senofilcon C (Type: OTHER): Lotrafilcon B contact lenses worn first, followed by senofilcon C contact lenses, as randomized. Each product worn bilaterally (in both eyes) for a total duration of 30 (+ 3) days under a daily wear modality for the specific study period. The lenses will be removed every night and cared for with the subject's habitual lens care solution.
- Senofilcon C, then lotrafilcon B (Type: OTHER): Senofilcon C contact lenses worn first, followed by lotrafilcon B contact lenses, as randomized. Each product worn bilaterally (in both eyes) for a total duration of 30 (+ 3) days under a daily wear modality for the specific study period. The lenses will be removed every night and cared for with the subject's habitual lens care solution.

Based on this trial design, predict the completion outcome and termination type (if applicable).